The glucose level-dependent hypoglycemic characteristics of GLP-1 are responsible for the very low incidence of hypoglycemia observed during the clinical treatment of type 2 diabetes mellitus (Drucker, 2006; Trujillo and Nuffer, 2014). This evidence concerns the gene GCG and Hypoglycemia.